Biotech · Private company
Skyline Therapeutics
Track this companyFree. Adds Skyline Therapeutics to your Dealase workspace and tells you when its record changes.
Clinical trials22 recruiting or active
Pipeline programs2From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline2
- SKG0106Phase 2 · Neovascular Age-related Macular DegenerationClinicalTrials.gov · fetched Nov 12, 2026
- SKG0106Neovascular (Wet) Age-related Macular DegenerationClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials2
- A Long-term Follow-up Study to Evaluate SKG0106 in the Treatment of Patients With nAMDRECRUITING · started Apr 2, 2025ClinicalTrials.gov NCT06346600 · fetched Nov 12, 2026
- Phase I/II Study of SKG0106 Intravitreal Injection in Patients With Neovascular Age-related Macular Degeneration (nAMD)PHASE1_PHASE2 · RECRUITING · started Feb 23, 2024ClinicalTrials.gov NCT05986864 · fetched Nov 12, 2026